Cowden Syndrome
RareGenetic Disorder
Cowden Syndrome is treated with 2 medications in our database, including WELIREG, BELRAPZO. 2 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Merck, Eagle. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Cowden Syndrome treatment below.
What help exists for Cowden Syndrome
2
drugs indexed
2
with copay cards
2
with patient assistance
1
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Cowden Syndrome
2 total🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Cowden Syndrome drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
Grants for Cowden Syndrome patients
6 total · 1 open- open
The Merck Co-pay Assistance Program
Merck
Covers: financial assistance
- unknown
The Merck Access Program
Merck
Covers: financial assistance
- unknown
Merck Patient Assistance Program (NeedyMeds)
NeedyMeds
Covers: financial assistance
- unknown
WELIREG Treatment Resources
Merck
Covers: hotels, meals, transportation
- unknown
Merck Patient Assistance Program
Merck
Covers: transportation, financial assistance
- unknown
The Merck Co-pay Assistance Program Enrollment Form
Merck
Covers: financial assistance
Cowden Syndrome is a rare disease — more resources at UniteRare
Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.
Visit UniteRare →